Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesetaxel in Advanced Melanoma
NCT01064713Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2010
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tesetaxel in melanoma (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: Response Rate at Day 84 and Number of Participants With Response at Day 84. Started Feb 2010; status: completed.
02
Drugs
tesetaxel
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01064713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01064713.